financetom
Business
financetom
/
Business
/
Muthoot FinCorp launches Rs 400 crore in NCDs in bid for capital growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Muthoot FinCorp launches Rs 400 crore in NCDs in bid for capital growth
Sep 4, 2023 7:30 AM

Gold loan company Muthoot FinCorp Ltd on Monday (September 4) said it has unveiled its 16th series of secured, redeemable, non-convertible debentures (NCDs), aiming to raise a substantial Rs 400 crore.

Share Market Live

NSE

This offering falls within the company's shelf limit of Rs 1,100 crore, signaling its intent to tap into the investment market effectively.

The inaugural tranche of Rs 100 crore, which includes a green shoe option of Rs 300 crore, forms the "Tranche I Issue." This offering, consisting of NCDs with a face value of Rs 1,000, was open to the public from September 1, 2023, and will remain accessible until September 14, 2023.

However, the issuance may close early at the discretion of the company's Board of Directors or a duly constituted committee, subject to relevant approvals and in compliance with Regulation 33A of the SEBI NCS Regulations.

Also Read: Exclusive | Kotak Mahindra Bank has sent two names for MD and CEO role to RBI: Uday Kotak

Investors can choose from multiple maturity/tenure options, including 24, 36, 60, and 96 months. Furthermore, the NCDs offer a range of payment options, such as monthly, annual, and cumulative, across schemes I to X, providing flexibility to investors.

The effective yield (per annum) for NCD holders spans from an enticing 8.65-9.43 percent.

CRISIL, a leading credit rating agency, has accorded the secured NCDs issued under Tranche I with an AA-/ Stable rating. These NCDs are set to be listed on the debt market segment of the Bombay Stock Exchange (BSE).

The capital raised from this offering will be channelled towards onward lending, financing activities, and servicing existing borrowings, including interest and principal repayments. It will also support the company's general corporate initiatives.

Also Read: This Rs 4,000 crore company has doubled this year and just made a $55 million acquisition

Shaji Varghese, CEO of Muthoot FinCorp, expressed confidence in the offering, stating, "Our strength lies in the trust and belief our customers have placed in us for over 136 years. I'm delighted to announce the 16th series of NCDs from Muthoot FinCorp."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved